Literature DB >> 18424001

Neuronal activity of orexin and non-orexin waking-active neurons during wake-sleep states in the mouse.

K Takahashi1, J-S Lin, K Sakai.   

Abstract

Using extracellular single unit recordings alone or in combination with neurobiotin juxtacellular labeling and orexin (hypocretin) immunohistochemistry in the mouse, we have recorded a total of 452 neurons in the orexin neuron field of the posterior hypothalamus. Of these, 76 exhibited tonic discharge highly specific to wakefulness, referred to as waking-active neurons. They showed differences from each other in terms of spike shape, activity profile, and response to an arousing sound stimulus and could be classified into three groups on the basis of spike shape as: 1) biphasic broad; 2) biphasic narrow; and 3) triphasic. Waking-active neurons characterized by biphasic broad spikes were orexin-immunopositive, whereas those characterized by either biphasic narrow or triphasic broad spikes were orexin-immunonegative. Unlike waking-specific histamine neurons, all orexin and non-orexin waking-active neurons exhibited slow (<10 Hz) tonic discharges during wakefulness and ceased firing shortly after the onset of electroencephalogram (EEG) synchronization (deactivation), the EEG sign of sleep (drowsy state). They remained virtually silent during slow-wave sleep, but displayed transient discharges during paradoxical (or rapid eye movement) sleep. During the transition from sleep to wakefulness, both orexin and triphasic non-orexin neurons fired in clusters prior to the onset of EEG activation, the EEG sign of wakefulness, and responded with a short latency to an arousing sound stimulus given during sleep. In contrast, the biphasic narrow non-orexin neurons fired in single spikes either prior to, or after, EEG activation during the same transition and responded to the stimulus with a longer latency. The activity of all waking-active neurons preceded the return of muscle tonus at the transition from paradoxical sleep to wakefulness. These data support the view that the activity of orexin and non-orexin waking-active neurons in the posterior hypothalamus plays an important wake-promoting role and that their activity antagonizes cortical deactivation and loss of muscle tone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424001     DOI: 10.1016/j.neuroscience.2008.02.058

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  94 in total

Review 1.  Hypothalamic control of sleep in aging.

Authors:  Asya Rolls
Journal:  Neuromolecular Med       Date:  2012-03-09       Impact factor: 3.843

2.  The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered.

Authors:  Mingchu Xi; Michael H Chase
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

Review 3.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

4.  Influence of inhibitory serotonergic inputs to orexin/hypocretin neurons on the diurnal rhythm of sleep and wakefulness.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Thomas S Kilduff; Shouta Sugio; Ming Xu; Kenji F Tanaka; Satoru Takahashi; Makoto Tominaga; Akihiro Yamanaka
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

5.  Hypocretin (orexin) is critical in sustaining theta/gamma-rich waking behaviors that drive sleep need.

Authors:  Anne Vassalli; Paul Franken
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 6.  State-dependent central chemoreception: a role of orexin.

Authors:  Tomoyuki Kuwaki; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2010-02-17       Impact factor: 1.931

7.  Abnormal sleep/wake dynamics in orexin knockout mice.

Authors:  Cecilia G Diniz Behn; Elizabeth B Klerman; Takatoshi Mochizuki; Shih-Chieh Lin; Thomas E Scammell
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

8.  Role of adenosine and the orexinergic perifornical hypothalamus in sleep-promoting effects of ethanol.

Authors:  Rishi Sharma; Pradeep Sahota; Mahesh M Thakkar
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

9.  A role for orexin in cytotoxic chemotherapy-induced fatigue.

Authors:  K B Weymann; L J Wood; X Zhu; D L Marks
Journal:  Brain Behav Immun       Date:  2013-11-09       Impact factor: 7.217

10.  State-dependent control of lumbar motoneurons by the hypocretinergic system.

Authors:  Jack Yamuy; Simon J Fung; Mingchu Xi; Michael H Chase
Journal:  Exp Neurol       Date:  2009-12-03       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.